Total Return chart Myriad Genetics, Inc.

Stocks

Market Closed - Nasdaq Other stock markets 00:00:00 18/07/2026 +04			5-day change	1st Jan Change
6.180 ^USD	-0.16%		+6.00%	+0.49%

07-02	Myriad Genetics Publishes Large-Scale Meta-Analysis Demonstrating Prognostic Performance of Prolaris Biopsy Test in Localized Prostate Cancer	CI
06-23	Myriad Genetics, Inc. Announces Resignation of Daniel M. Skovronsky from Director, Effective June 17, 2026	CI

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.